These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34629365)

  • 1. GINS Complex Subunit 2 Facilitates Gastric Adenocarcinoma Proliferation and Indicates Poor Prognosis.
    Feng H; Zeng J; Gao L; Zhou Z; Wang L
    Tohoku J Exp Med; 2021 Oct; 255(2):111-121. PubMed ID: 34629365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
    Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
    Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
    Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1.
    Hu H; Ye L; Liu Z
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
    Peng L; Song Z; Chen D; Linghu R; Wang Y; Zhang X; Kou X; Yang J; Jiao S
    Biomed Pharmacother; 2016 Dec; 84():1568-1574. PubMed ID: 27829549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognosis analysis of GINS subunits in human breast cancer.
    Li H; Cao Y; Ma J; Luo L; Ma B
    Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
    Chi F; Wang Z; Li Y; Chang N
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma.
    Tang Y; Peng X; Huang X; Li J
    Saudi J Gastroenterol; 2022; 28(3):239-246. PubMed ID: 34856725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2.
    Ye Y; Song YN; He SF; Zhuang JH; Wang GY; Xia W
    Cancer Gene Ther; 2019 Mar; 26(3-4):103-113. PubMed ID: 30177819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
    Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway.
    He S; Zhang M; Ye Y; Song Y; Ma X; Wang G; Zhuang J; Xia W; Zhao B
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.
    Chen W; Lu C; Hong J
    Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.
    Shen YL; Li HZ; Hu YW; Zheng L; Wang Q
    CNS Neurosci Ther; 2019 Feb; 25(2):273-287. PubMed ID: 30338650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
    Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
    J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GINS complex subunit 2 (GINS2) plays a protective role in alcohol-induced brain injury.
    Liu C; Wang R; Zhang Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1-9. PubMed ID: 30513217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2.
    Rantala JK; Edgren H; Lehtinen L; Wolf M; Kleivi K; Vollan HK; Aaltola AR; Laasola P; Kilpinen S; Saviranta P; Iljin K; Kallioniemi O
    Neoplasia; 2010 Nov; 12(11):877-88. PubMed ID: 21082043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers.
    Shan DD; Zheng QX; Chen Z
    World J Gastrointest Oncol; 2022 Oct; 14(10):1892-1902. PubMed ID: 36310704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.